Researchers at the University of South Australia have developed a long-acting injectable formulation that provides a consistent dose of levodopa and carbidopa—two essential Parkinson’s medications—over the course of a week. SBS Hindi spoke with lead researcher Professor Sanjay Garg about how the two-year old study which could represent a breakthrough for those affected by Parkinson’s. Parkinson’s Australia, the leading advocacy organisation, reports that more than 150,000 Australians are living with Parkinson’s disease.